0001214659-19-002838.txt : 20190423 0001214659-19-002838.hdr.sgml : 20190423 20190422204630 ACCESSION NUMBER: 0001214659-19-002838 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190423 DATE AS OF CHANGE: 20190422 EFFECTIVENESS DATE: 20190423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-337858 FILM NUMBER: 19760453 BUSINESS ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 D 1 primary_doc.xml X0708 D LIVE 0001677077 Alzamend Neuro, Inc. 3802 SPECTRUM BLVD, SUITE 112C TAMPA FL FLORIDA 33612 844-722-6333 DELAWARE None None Corporation true 2016 Stephan Jackman 3802 Spectrum Boulevard Suite 112C Tampa FL FLORIDA 33612 Executive Officer Chief Executive Officer Milton C. Ault 3802 Spectrum Boulevard Suite 112C Tampa FL FLORIDA 33612 Director CHAIRMAN OF THE BOARD William B. Horne 3802 Spectrum Boulevard Suite 112C Tampa FL FLORIDA 33612 Director Philip E. Mansour 3802 Spectrum Boulevard Suite 112C Tampa FL FLORIDA 33612 Director Kenneth S. Cragun 3802 Spectrum Boulevard Suite 112C Tampa FL FLORIDA 33612 Executive Officer CHIEF FINANCIAL OFFICER Biotechnology Decline to Disclose 06b false 2019-03-04 false true true true false 999 2000000 231519 1768481 On 3/04/19, the Issuer sold and issued to accredited investors an aggregate of 154,346 shares of common stock at $1.50 per share, and warrants to purchase 77,173 shares, in the aggregate, at an exercise price of $3.00. false 17 0 0 0 false Alzamend Neuro, Inc. /s/ Stephan Jackman Stephan Jackman Chief Executive Officer 2019-04-19